How is Succinic semialdehyde dehydrogenase deficiency diagnosed?

Succinic semialdehyde dehydrogenase (SSADH) deficiency is primarily diagnosed through the detection of elevated 4-hydroxybutyric acid (GHB) in urine via organic acid analysis, followed by confirmation through molecular genetic testing of the ALDH5A1 gene. Because symptoms are often non-specific, clinical suspicion is the most critical factor in initiating the diagnostic process for this rare metabolic disorder.

How is Succinic semialdehyde dehydrogenase deficiency diagnosed?

The diagnostic process for Succinic semialdehyde dehydrogenase deficiency typically begins when a clinician suspects a metabolic disorder due to developmental delays, hypotonia, or seizures. The first line of investigation is usually a urine organic acid analysis, which typically reveals a massive elevation of 4-hydroxybutyric acid (GHB). If this screening test is positive, the diagnosis is confirmed through genetic testing to identify pathogenic variants in the ALDH5A1 gene. While enzyme activity assays in lymphocytes or cultured skin fibroblasts were historically used, genetic sequencing has become the gold standard for confirming Succinic semialdehyde dehydrogenase deficiency.

Why do patients experience a long "diagnostic odyssey"?

The journey to a diagnosis for Succinic semialdehyde dehydrogenase deficiency can be incredibly isolating, often spanning years. Because the condition is ultra-rare, many pediatricians and general neurologists may never encounter a case in their entire career. Patients often endure multiple misdiagnoses, such as cerebral palsy, autism spectrum disorder, or idiopathic epilepsy, before a metabolic specialist considers the correct diagnosis. We recognize the profound frustration this delay causes for families, and it is important to know that your persistence in seeking answers is justified.

Which medical specialists should be involved?

Because Succinic semialdehyde dehydrogenase deficiency is a complex metabolic condition, diagnosis and ongoing management are best handled by a multidisciplinary team. You should seek care from:

• Metabolic Geneticists: They are the primary specialists equipped to interpret metabolic screening results and coordinate genetic testing.


• Pediatric Neurologists: They help manage the associated seizure disorders and neurodevelopmental symptoms.


• Genetic Counselors: They provide essential support in understanding the inheritance patterns and the implications for other family members.

What conditions can be confused with Succinic semialdehyde dehydrogenase deficiency?

Due to the overlapping clinical presentation, Succinic semialdehyde dehydrogenase deficiency is frequently confused with other neurodevelopmental disorders. Differential diagnoses that clinicians must rule out include:

• Other organic acidurias or urea cycle disorders.


• Genetic epilepsy syndromes (such as Dravet syndrome or Lennox-Gastaut syndrome).


• Non-specific global developmental delay or intellectual disability.


• Primary mitochondrial disorders that present with hypotonia and ataxia.

Next steps

• Consult with a metabolic specialist or a center of excellence for inborn errors of metabolism.


• Request a referral to a clinical geneticist if you suspect a hereditary cause for neurological symptoms.


• Connect with the 13 members currently sharing their experiences on DiseaseMaps.org to learn how others navigated their diagnostic process.


• Maintain a detailed symptom log and developmental history to provide your specialists with the most accurate clinical picture.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding your specific medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Succinic semialdehyde dehydrogenase deficiency.


• Orphanet: Succinic semialdehyde dehydrogenase deficiency (ORPHA:3199).


• OMIM (Online Mendelian Inheritance in Man): Succinic semialdehyde dehydrogenase deficiency (#271980).


• The SSADH Association: Patient resources and clinical research updates.